The family of a 63-year-old man, who died in March in Haute-Savoie of "
multiple thromboses
" after receiving a first injection of AstraZeneca's anti-Covid vaccine, filed a complaint against X for "
manslaughter
", indicated Tuesday April 6 the parquet of Annecy.
"
The complaint was lodged with me urgently this Tuesday morning
", confirmed to AFP Véronique Denizot, the public prosecutor of Annecy.
Read also: A lead to explain the rare thromboses linked to the AstraZeneca vaccine
This is not the first procedure targeting the vaccine from the Anglo-Swedish laboratory: a complaint against X was filed in Toulouse after the death of a 38-year-old woman and the Nantes public prosecutor's office opened a preliminary investigation in following the death of a medical student.
These complaints could be examined jointly by the Paris prosecutor's office as part of a grouping.
Otherwise, Véronique Denizot left the door open to the "
referral of an examining magistrate
".
According to the regional daily
Le Dauphiné Libéré
, which revealed the information, the complaint was recorded by the gendarmes of Seynod on Friday April 2, a little more than two weeks after the death, on March 18 in Annecy, of this sixty-year-old who came to receive the first injection of the controversial anti-Covid vaccine.
His relatives reported the tragedy to the National Medicines Safety Agency (ANSM), which ordered additional information to clarify the causes of his death.
"
It was dazzling
"
Persuaded "
at 95%
" that a link with the vaccination can be established, the relatives of the victim try to have his death recognized as a consequence of the injection and to include it in the report on the adverse effects of AstraZeneca.
“
In the space of a day and a half, he multiplied problems after problems, thromboses on vital organs, the liver, the kidneys, the brain… then he was placed in intensive care.
It was dazzling,
”testifies his brother in a video published by the daily on its website.
On Tuesday, Rogerio Pinto de Sa Gaspar, the director of the World Health Organization (WHO), estimated that the risk / benefit balance continued to weigh "
largely
" in favor of the use of AstraZeneca's anti-Covid vaccine .
The European Medicines Agency (EMA) said it was still assessing the safety of the vaccine in light of this new information.
